What Is Horrible Plastic Surgery and How Common Is It
Horrible plastic surgery refers to procedures that result in severe complications, disfigurement, or outcomes requiring corrective surgery. The American Society of Plastic Surgeons reports that in the most recent full-year data, there were over 1.8 million surgical cosmetic procedures in the United States, with a small but significant share leading to major complications. Revision rates for certain minimally invasive and surgical procedures range from 5% to 15%, depending on the intervention and patient factors. The ASPS also tracks board-certified surgeon participation, which helps contextualize outcomes across different practice settings. Forbes analysis of rising cosmetic surgery costs notes that price competition and marketing can drive patients toward lower-cost providers with variable safety records.
Severe adverse events include infection, necrosis, nerve damage, and anesthesia complications, according to data from the American Society for Aesthetic Plastic Surgery. The AAFPRS and ASAPS publish complication benchmarks that help distinguish routine risks from catastrophic outcomes. Regulatory bodies such as the FDA monitor device-related adverse events, including implants and injectables, through its MAUDE database. Public reporting of these events allows patients and researchers to compare facility-level safety profiles and surgeon-specific outcomes.
Financial and Legal Dimensions of Failed Procedures
Costs associated with horrible plastic surgery extend beyond the initial procedure. Patients often face additional expenses for revision surgeries, hospitalization, and long-term care. The average cost of a single revision rhinoplasty, for example, can exceed $15,000 when complex reconstructive work is required. Insurance typically does not cover elective cosmetic revisions, leaving patients with substantial out-of-pocket burdens. The SEC requires publicly traded hospital chains to disclose malpractice settlements and litigation reserves, which can signal systemic issues at specific facilities.
Malpractice lawsuits and board disciplinary actions provide another lens on the financial impact of poor outcomes. State medical boards publish disciplinary records that reveal patterns of negligence or unlicensed practice. Class-action lawsuits against device manufacturers, such as those involving certain breast implants or dermal fillers, have resulted in multi-million dollar settlements. These legal and financial consequences influence market dynamics, insurer underwriting, and hospital credentialing decisions.
How to Identify and Avoid High-Risk Providers
Consumers can use verified databases to check surgeon credentials and facility accreditation. The American Board of Medical Specialties maintains a searchable directory of board-certified plastic surgeons, while the Accreditation Association for Ambulatory Health Care certifies surgical centers. Research published in peer-reviewed journals consistently shows that board certification and accredited facilities are correlated with lower complication rates. Patients should also verify whether a provider has faced FDA warning letters or state board sanctions.
Red flags include unrealistic promises, pressure to book multiple procedures simultaneously, and lack of clear before-and-after documentation. The FDA advises patients to confirm that injectable products are FDA-approved and administered by licensed professionals. Online review platforms and state medical board websites allow patients to cross-reference complaints and disciplinary history. Combining verified credential checks with independent patient outcome data reduces the risk of selecting a high-risk provider.